BTIG analyst Clark Lampen adjusted the price target for Roblox Corp . (NYSE:RBLX) shares, raising it to $73 from the previous $66, while maintaining a Buy rating on the stock. The reevaluation ...

In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Haemonetics (HAE – Research Report), with a price target of ...

BTIG analysts upheld their Buy rating and $15.00 price target for Coya Therapeutics (NASDAQ:COYA), following recent clinical trial data. The stock, currently trading at $7.11, has shown strong ...

BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article ...

BTIG Research lowered shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com reports. Several other ...

Performant Healthcare, Inc. (Nasdaq: PHLT) ("Performant"), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that it will ...

Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently ...

On Thursday, BTIG analyst Andre Madrid confirmed his Buy rating and $190.00 price target for FTAI Aviation (NASDAQ: FTAI) stock, despite recent accusations of financial misconduct. The company ...

But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 500's rally off this week's lows is quite impressive and sets up the stock barometer ...